3rd Quarter - Report
K&L GATES, LLP for PEAR THERAPEUTICS, INC.
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.7051, S.3791, Access to Prescription Digital Therapeutics Act of 2022; Federal policy related to prescription digital therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT ALIFERIS | — |
| AMY CARNEVALE | — |
| BRENDEN R. CHAINEY New | Legislative Assistant, Legislative Counsel and Legislative Director, Rep. Chaka Fatah |
| JEFFREY J. DENHAM New | U.S. Congressman |
| PAMELA GARVIE | — |
| BART GORDON | — |
| VICTORIA K. HAMSCHO | — |
| SCOTT NELSON | — |
| DENNIS POTTER | — |
| SARAH SWANSON New | Intern, Senator Chris Murphy; Intern/Staff Assistant/Executive Assistant, Senator Tom Carper |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.